Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Epic American Credit and Bond Bubble Laboratory -- Ignore unavailable to you. Want to Upgrade?

To: mishedlo who wrote (36843)	7/24/2005 3:00:46 PM
From: russwinter	Read Replies (1) \| Respond to of 110194

There is a big difference between two large or mid tiers merging or "paper shuffling", and a larger company buying out a smaller development name. The point I'm making is that it's about "pipeline development". I know in modern Bubble economics people think it's just about paper shuffling or what I call synthetic economics. But resource (and as smh points out correctly in his post, pharma) companies have to replace production (or tired old drugs going off patent), not just combine things. More importantly those reserves then need to be actually mined. I have always questioned the ability of small cap juniors to engage in economic mining, don't think they do it that well. The acquistion of a development play is a completely different and more powerful animal than just combining company A and B reserves, and just increasing shares outstanding. But tell that to the clowns who run these companies.